HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The company’s Growth Portfolio delivered $6.2 billion in revenue
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The deal, backed by healthcare investor ARCHIMED, signals a major push to accelerate connected, patient-centered cardiac care worldwide
Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
nSEPIA aims to bring structure to an area long dominated by subjectivity
Subscribe To Our Newsletter & Stay Updated